Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3971826 | 0.90 | ALDH1A1 (0.48) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL3970085 | 0.86 | ALDH1A1 (0.44) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL3973962 | 0.85 | ALDH1A1 (0.46) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL3972889 | 0.84 | HPGD (0.51) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL3971476 | 0.80 | ALDH1A1 (0.58) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL5995027 | 0.79 | HPGD (0.57) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL4672321 | 0.76 | PTPN1 (0.49) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL3970328 | 0.75 | ALDH1A1 (0.55) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL4670702 | 0.75 | ALDH1A1 (0.56) | MAPK14ALDH1A1MAPK1MAPTHPGD | |
| SCHEMBL4672311 | 0.74 | ALDH1A1 (0.47) | MAPK14ALDH1A1MAPK1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534894-B2 | Biphenyloxy-acids | WYETH (US) | 2009-05-19 | — | — | US | disclosed |
| EP-1667959-A1 | BIPHENYLOXY-ACIDS | Wyeth (US) | 2006-06-14 | — | — | EP | disclosed |
| US-20060020003-A1 | Biphenyloxy-acids | WYETH (US) | 2006-01-26 | — | — | US | disclosed |
| WO-2005030702-A1 | BIPHENYLOXY-ACIDS | WYETH (US) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020003-A1 | Biphenyloxy-acids | AHR, ARNT, NR1H4 | MAPK14 4213/4885ALDH1A1 388/4885MAPK1 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.